Promoter polymorphisms of the vascular endothelial growth factor gene are associated with metabolic syndrome susceptibility in Koreans

Kim,Young Ree; Hong,Seung‑Ho

doi:10.3892/br.2017.886

Promoter polymorphisms of the vascular endothelial growth factor gene are associated with metabolic syndrome susceptibility in Koreans

Authors:
- Young Ree Kim
- Seung‑Ho Hong
View Affiliations

Affiliations: Department of Laboratory Medicine, School of Medicine, Jeju National University, Jeju 63243, Republic of Korea, Department of Science Education, Teachers College, Jeju National University, Jeju 63294, Republic of Korea
Published online on: April 7, 2017 https://doi.org/10.3892/br.2017.886
Pages: 555-560

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Vascular endothelial growth factor (VEGF) is a potent regulator of angiogenesis. Patients with metabolic syndrome (MetS) have elevated plasma VEGF levels. The aim of the present study was to investigate the association between promoter polymorphisms (the ‑2578C>A and ‑1154G>A) of the VEGF gene and MetS susceptibility. A total of 640 subjects were enrolled in the study including 320 patients with MetS and 320 healthy controls. Genotyping of the VEGF single nucleotide polymorphisms was performed by polymerase chain reaction‑restriction fragment length polymorphism analysis. The CA and AA genotypes of the ‑2578C>A polymorphism were associated with decreased risk of MetS (P=0.018, P=0.003, respectively). For the ‑1154G>A polymorphism, although the GA genotype was more significantly frequent in MetS patients (P=0.022), the AA genotype and recessive model (GG+GA vs. AA) were protective against MetS susceptibility (P=0.016, 0.007, respectively). The A‑G haplotype frequency composed of the ‑2578C>A and ‑1154G>A polymorphisms also differed between the 2 groups (P=0.011). The presented data suggested that the A alleles and A‑G haplotype of the VEGF ‑2578C>A and ‑1154G>A polymorphisms are associated with decreased MetS susceptibility. To the best of the authors' knowledge, the current study is the first to investigate the associations between the VEGF ‑2578C>A and ‑1154G>A polymorphisms and MetS patients. Further evaluation is necessary to explore the associations between the VEGF polymorphisms and MetS patients in larger samples of other ethnic or racial populations.

View Figures

View References

1	Renner W and Pilger E: Simultaneous in vitro quantitation factors of vascular endothelial growth factor mRNA splice variants. J Vasc Res. 36:133–138. 1999. View Article : Google Scholar : PubMed/NCBI
2	Gargett CE and Rogers PA: Human endometrial angiogenesis. Reproduction. 121:181–186. 2001. View Article : Google Scholar : PubMed/NCBI
3	Tischer E, Mitchell R, Harrman T, Silva M, Gospodarowicz D, Fiddes JC and Abraham JA: The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem. 266:11947–11954. 1991.PubMed/NCBI
4	Minchenko A, Bauer T, Salceda S and Caro J: Hypoxic stimulation of vascular endothelial expression in vitro and in vivo. Lab Invest. 71:374–379. 1994.PubMed/NCBI
5	Shahbazi M, Fryer AA, Pravica V, Brogan IJ, Ramsay HM, Hutchinson IV and Harden PN: Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol. 13:260–264. 2002.PubMed/NCBI
6	Steffensen KD, Waldstrøm M, Brandslund I and Jakobsen A: The relationship of VEGF polymorphisms with serum VEGF levels and progression-free survival in patients with epithelial ovarian cancer. Gynecol Oncol. 117:109–116. 2010. View Article : Google Scholar : PubMed/NCBI
7	Watson CJ, Webb NJ, Bottomley MJ and Brenchley PE: Identification of polymorphisms within the vascular endothelial growth factor gene: Correlation with variation in VEGF protein production. Cytokine. 12:1232–1235. 2000. View Article : Google Scholar : PubMed/NCBI
8	Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B and Pilger EA: Common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res. 37:443–448. 2000. View Article : Google Scholar : PubMed/NCBI
9	Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Wolf G, Wascher TC, Paulweber B, Haas J and Samonigg H: A common 936 C/T gene polymorphisms of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer. 106:468–471. 2003. View Article : Google Scholar : PubMed/NCBI
10	Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, et al: Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung and Blood Institute Scientific Statement. Circulation. 112:2735–2752. 2005. View Article : Google Scholar : PubMed/NCBI
11	Janghorbani M and Amini M: Associations of hip circumference and height with incidence of type 2 diabetes: The Isfahan diabetes prevention study. Acta Diabetol. 49:(Suppl 1). S107–S114. 2012. View Article : Google Scholar : PubMed/NCBI
12	Wannamethee SG, Shaper AG, Lennon L and Morris RW: Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med. 165:2644–2650. 2005. View Article : Google Scholar : PubMed/NCBI
13	Ervin RB: Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003–2006. Natl Health Stat Report. 13:1–7. 2009.
14	Barylski M, Kowalczyk E, Banach M, Ciecwierz J, Pawlicki L and Kowalski J: Plasma total antioxidant activity in comparison with plasma NO and VEGF levels in patients with metabolic syndrome. Angiology. 60:87–92. 2009. View Article : Google Scholar : PubMed/NCBI
15	Siervo M, Ruggiero D, Sorice R, Nutile T, Aversano M, Stephan BC and Ciullo M: Angiogenesis and biomarkers of cardiovascular risk in adults with metabolic syndrome. J Intern Med. 268:338–347. 2010. View Article : Google Scholar : PubMed/NCBI
16	Siervo M, Ruggiero D, Sorice R, Nutile T, Aversano M, Iafusco M, Vetrano F, Wells JC, Stephan BC and Ciullo M: Body mass index is directly associated with biomarkers of angiogenesis and inflammation in children and adolescents. Nutrition. 28:262–266. 2012. View Article : Google Scholar : PubMed/NCBI
17	Kim YR and Hong SH: Association between the polymorphisms of the vascular endothelial growth factor gene and metabolic syndrome. Biomed Rep. 3:319–326. 2015.PubMed/NCBI
18	Park YS, Jeon YJ, Kim HS, Chae KY, Oh SH, Han IB, Kim HS, Kim WC, Kim OJ, Kim TG, et al: The role of VEGF and KDR polymorphisms in moyamoya disease and collateral revascularization. PLoS One. 7:e471582012. View Article : Google Scholar : PubMed/NCBI
19	Fernández-Santiago R, Sharma M, Mueller JC, Gohlke H, Illig T, Anneser J, Münch C, Ludolph A, Kamm C and Gasser T: Possible gender-dependent association of vascular endothelial growth factor (VEGF) gene and ALS. Neurology. 66:1929–1931. 2006. View Article : Google Scholar : PubMed/NCBI
20	Yang B, Cross DF, Ollerenshaw M, Millward BA and Demaine AG: Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus. J Diabetes Complications. 17:1–6. 2003. View Article : Google Scholar : PubMed/NCBI
21	Liu Q, Li Y, Zhao J, Sun DL, Duan YN, Wang N, Zhou RM and Kang S: Association of polymorphisms −1154G/A and −2578C/A in the vascular endothelial growth factor gene with decreased risk of endometriosis in Chinese women. Hum Reprod. 24:2660–2666. 2009. View Article : Google Scholar : PubMed/NCBI
22	Maltese P, Canestrari E, Ruzzo A, Graziano F, Falcone A, Loupakis F, Tonini G, Santini D and Magnani M: VEGF gene polymorphisms and susceptibility to colorectal cancer disease in Italian population. Int J Colorectal Dis. 24:165–170. 2009. View Article : Google Scholar : PubMed/NCBI
23	Howell WM, Ali S, Rose-Zerilli MJ and Ye S: VEGF polymorphisms and severity of atherosclerosis. J Med Genet. 42:485–490. 2005. View Article : Google Scholar : PubMed/NCBI
24	Jeon YJ, Kim JH, Rah H, Kim SY, Yoon TK, Choi DH, Cha SH, Shim SH and Kim NK: Vascular endothelial growth factor gene polymorphisms in spontaneously aborted fetuses. Am J Reprod Immunol. 66:544–553. 2011. View Article : Google Scholar : PubMed/NCBI
25	McCarron SL, Edwards S, Evans PR, Gibbs R, Dearnaley DP, Dowe A, Southgate C, Easton DF, Eeles RA and Howell WM: Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res. 62:3369–3372. 2002.PubMed/NCBI
26	Howell WM, Bateman AC, Tumer SJ, Collins A and Theaker JM: Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumour development in cutaneous malignant melanoms. Genes Immun. 3:229–232. 2002. View Article : Google Scholar : PubMed/NCBI
27	Papazoglou D, Galazios G, Papatheodorou K, Liberis V, Papanas N, Maltezos E and Maroulis GB: Vascular endothelial growth factor gene polymorphisms and idiopathic recurrent pregnancy loss. Fertil Sterril. 83:959–963. 2005. View Article : Google Scholar
28	Hefler LA, Mustea A, Könsgen D, Concin N, Tanner B, Strick R, Heinze G, Grimm C, Schuster E, Tempfer C, et al: Vascular endothelial growth factor gene polymorphisms are associated with prognosis in ovarian cancer. Clin Cancer Res. 13:898–901. 2007. View Article : Google Scholar : PubMed/NCBI
29	Schneider BP, Radovich M, Sledge GW, Robarge JD, Li L, Storniolo AM, Lemler S, Nguyen AT, Hancock BA, Stout M, et al: Association of polymorphisms of angiogenesis genes with breast cancer. Breast Cancer Res Treat. 111:157–163. 2008. View Article : Google Scholar : PubMed/NCBI
30	Sfar S, Saad H, Mosbah F and Chouchane L: Combined effects of the angiogenic genes polymorphisms on prostate cancer susceptibility and aggressiveness. Mol Biol Rep. 36:37–45. 2009. View Article : Google Scholar : PubMed/NCBI
31	Koukourakis MI, Papazoglou D, Giatromanolaki A, Bougioukas G, Maltezos E and Sivridis E: VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer. Lung Cancer. 46:293–298. 2004. View Article : Google Scholar : PubMed/NCBI
32	Lambrechts D, Storkebaum E, Morimoto M, Del-Favero J, Desmet F, Marklund SL, Wyns S, Thijs V, Andersson J, van Marion I, et al: VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet. 34:383–394. 2003. View Article : Google Scholar : PubMed/NCBI
33	Fu Y, Ni P, Ma J, Ying Y, Zhao J, Liu J and Chen S: Polymorphisms of human vascular endothelial growth factor gene are associated with acute cerebral infarction in the Chinese population. Eur Neurol. 66:47–52. 2011. View Article : Google Scholar : PubMed/NCBI
34	Park HM, Hong SH, Kim JW, Oh D, Hwang SG, An HJ, An HJ, Kim UK and Kim NK: Gender-specific association of the VEGF −2578C>A polymorphism in Korean patients with colon cancer. Anticancer Res. 27:2535–2539. 2007.PubMed/NCBI
35	Muniz JJ, Izidoro-Toledo TC, Metzger IF, Sandrim VC and Tanus-Santos JE: Interethnic differences in the distribution of clinically relevant vascular endothelial growth factor genetic polymorphisms. DNA Cell Biol. 28:567–572. 2009. View Article : Google Scholar : PubMed/NCBI
36	Lee HH, Hong SH, Shin SJ, Ko JJ, Oh D and Kim NK: Association study of vascular endothelial growth factor polymorphisms with the risk of recurrent spontaneous abortion. Fertil Steril. 93:1244–1247. 2010. View Article : Google Scholar : PubMed/NCBI
37	Choi YS, Choi JK, Kim JW, Min KT, Kwon YD, Jang MJ, Chong SY, Oh D, Cho YK, Hong SH and Kim NK: Association of the vascular endothelial growth factor (VEGF −1154G>A) polymorphism in patients with colorectal cancer. Genes Genomics. 33:133–138. 2011. View Article : Google Scholar